Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Aug 26, 2022 10:30am
281 Views
Post# 34922338

RE:The ROT in Spectral, a Casual Observation

RE:The ROT in Spectral, a Casual ObservationGorf79 I agree with you completely.  Even if you value PMX at zero (this is only theoretical as I think it's likely worth at least $10 per share right now at this stage of the Tigris trial) - the EAA is completely approved worldwide and valuable. 

In terms of Dialco SAMI is approved and SELLING, DIMI is fully approved in Canada and in the US it is fully approved save and except for home use.  But management tells us approval for home use is a when not if so Dialco has full value right now - I think that's at least $5 per share.

So based on all this the company is worth $15 a share or better RIGHT NOW or even if you give PMX a zero value the company is worth $5 a share or better RIGHT NOW.  If a financing is done at a stupidly low share price AGAIN then management and governance will prove your assertion beyond the shadow of a doubt.  And shame on them if they come out derelict in their duties confirming the ROT.
<< Previous
Bullboard Posts
Next >>